A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We developed a protocol to assess well-being in mice during procedures using general anesthesia. A series of behavioral parameters indicating levels of well-being as well as glucocorticoid metabolites were analyzed. The protocol can serve as a general aid to estimate the degree of severity in a scientific, animal-centered manner.
In keeping with the 3R Principle (Replacement, Reduction, Refinement) developed by Russel and Burch, scientific research should use alternatives to animal experimentation whenever possible. When there is no alternative to animal experimentation, the total number of laboratory animals used should be the minimum needed to obtain valuable data. Moreover, appropriate refinement measures should be applied to minimize pain, suffering, and distress accompanying the experimental procedure. The categories used to classify the degree of pain, suffering, and distress are non-recovery, mild, moderate, or severe (EU Directive 2010/63). To determine which categories apply in individual cases, it is crucial to use scientifically sound tools.
The well-being-assessment protocol presented here is designed for procedures during which general anesthesia is used. The protocol focuses on home cage activity, the Mouse Grimace Scale, and luxury behaviors such as burrowing and nest building behavior as indicators of well-being. It also uses the free exploratory paradigm for trait anxiety-related behavior. Fecal corticosterone metabolites as indicators of acute stress are measured over the 24-h post-anesthetic period.
The protocol provides scientifically solid information on the well-being of mice following general anesthesia. Due to its simplicity, the protocol can easily be adapted and integrated in a planned study. Although it does not provide a scale to classify distress in categories according to the EU Directive 2010/63, it can help researchers estimate the degree of severity of a procedure using scientifically sound data. It provides a way to improve the assessment of well-being in a scientific, animal-centered manner.
EU Directive 2010/631 stipulates that the 3R Principle (Replacement, Reduction, Refinement) developed by Russel and Burch2 is to be applied whenever animal experimentation is necessary. The ultimate goal of the EU Directive is to phase out all animal testing, but the Directive acknowledges that, for the time being, some animal experiments are still needed to conduct research that will protect human and animal health. Thus, if an animal experiment cannot be replaced by any alternative method, only the minimum number of laboratory animals is to be used to obtain reliable results. In addition, the amount of pain, suffering, and distress accompanying experimental procedures should be minimized using appropriate refinement measures. EU Directive 2010/63 stipulates that the severity of a procedure must be prospectively classified as non-recovery, mild, moderate, or severe1. As severity classification is decided on a case-by-case basis, it is important to have scientifically sound tools to estimate the severity of a given procedure.
Score sheets as proposed by Morton and Griffith3 are an essential tool in detecting any deviations from normal status, including negative effects on well-being4. Score sheets are used to retrospectively determine pain, suffering, and distress caused by an experiment and focus on visible changes in the physical state of the individual animal (e.g., body weight, fur, gait). Although, Annex VIII of EU Directive 2010/63 provides examples of each severity category, researchers still lack tools to estimate the degree of severity of a given procedure using scientifically based data.
The absence of indicators showing negative well-being is not the only way to determine the state of the animal; the presence of indicators pointing to positive well-being is also important5,6,7,8. For example, animals display luxury behaviors like burrowing and nest building behavior only when all their essential needs are met. If well-being is reduced, luxury behaviors are the first to decline5,7. Protocols to be used in assessing well-being should include indicators pointing to the physical, physiological/biochemical, and psychological states of animals in order to evaluate their well-being in a detailed and comprehensive manner9.
Within the context of refinement, a protocol was developed to meet these requirements and to assess the effects of a procedure involving general anesthesia on well-being of mice10. At the same time, the goal was to minimize any additional stress to enable the easy integration of the protocol into a given experiment. The protocol considers burrowing behavior, home cage behavior such as activity, food intake, and nesting, and trait anxiety-related behavior. In addition, it includes the Mouse Grimace Scale (MGS), and the non-invasive analysis of corticosterone metabolites in feces. The protocol is designed to facilitate the assessment of well-being in a scientific and animal-centered manner and to provide information on well-being that supports the classification of the degree of severity. In addition to score sheets, it can provide useful information for the severity classification of a procedure. As the protocol is easy to carry out and does not require extensive equipment, it can be integrated into an ongoing experiment without influencing the results of a study. It should be noted that the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guideline11 is to be observed in all studies involving animal experiments, with the goal of improving design, analysis, and reporting.
Access restricted. Please log in or start a trial to view this content.
The study was performed according to the guidelines laid down by the German Animal Welfare Act and was approved by the Berlin State Authority ("Landesamt für Gesundheit und Soziales", permit number: G0053/15).
NOTE: The main objective of this protocol was to investigate the effect of repeated anesthesia on glucocorticoid metabolites. A sample size calculation was performed to determine the number of animals to be used: n ≥ 2 × (s/µ1- µ2)2 × (zα + zβ)2. µ1- µ2 is the difference between population means at which power and sample size calculations are made (α = 5%, β = 80%); zα = 1.96 and zβ = 0.84 are the quantiles of the standard normal distribution. Figure 1 illustrates the time line of this protocol. If a parameter of the protocol shows a difference with the control level, the animal should be closely monitored, and the parameter should be measured again after a suitable period. For example, if trait anxiety-related behavior is increased, this behavior should be tested again a week later, in order to help determine the period until full recovery. Time points and periods defined in this protocol can be adapted for use with other procedures. When changing time points, habituation periods should be kept as described in the protocol. In order to reduce factors that might influence the mice's behavior, tests requiring more manipulation should be conducted after tests that do not disturb the normal behavior of mice. Figure 2 summarizes all tests of the protocol using a summary scoring sheet. Figure 3 provides simplified scales of the grade of well-being, which give an overview of how to interpret the test results.
1. Habituating mice to handling by experimenter
2. Preparing the behavioral testing room and apparatuses
NOTE: Provide a separate room for testing, ideally near the room where the animals are kept. Transport the mice in their home cages to the testing room at least 60 min before the procedure is conducted. If possible, conduct all tests of this protocol in the same testing room where the procedure is carried out.
3. Mouse Grimace Scale
NOTE: Photographs for the MGS are taken in the observation cage at three time points: (i) 2 days prior to the procedure to record baseline MGS levels, (ii) 30 min after the procedure, and (iii) 150 min after the procedure. When well-being is impaired, scores on the MGS increase. If increased MGS scores are still observed after 150 min, take additional photographs at a later stage.
4. Burrowing behavior8,15,16
5. 24-h observation period
NOTE: Mice are housed individually, as described in 2.2. (Figure 5), for a period of 24 h, in order to measure food intake, home cage activity, nest building behavior, and FCM levels. The 24-h observation takes place twice: (i) 2 days prior to the procedure for baseline levels, (ii) on the day of the procedure.
6. Free exploratory paradigm
Access restricted. Please log in or start a trial to view this content.
This protocol was originally developed to assess well-being of C57BL/6JRj mice following a single experience of isoflurane anesthesia (one 45-min anesthesia session, n = 13 females) or repeated isoflurane anesthesia (six 45-min anesthesia sessions with 3 - 4 days between the anesthesia sessions, n = 13 females) compared with the well-being of control mice (n = 6 females)10, which received no anesthesia but were tested according to the same measures. We assessed the...
Access restricted. Please log in or start a trial to view this content.
The protocol was originally developed to assess well-being of C57BL/6JRj mice that received either a single anesthesia or repeated isoflurane anesthesia. The results confirm that tests of luxury behaviors, as well as other measures (e.g. the free exploratory paradigm, the MGS, burrowing food intake) were sensitive methods for assessing well-being. Repeated isoflurane anesthesia caused short-term effects on trait anxiety-related behavior, the MGS, and burrowing behavior. Moreover, repeated isoflurane anesthesia a...
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
Thanks to Sabine Jacobs for assisting with the sample collection, Edith Klobetz-Rassam for analysis of FCM, PD Dr. med. vet. habil. Roswitha Merle for assisting with statistical analysis, and Wiebke Gentner for proofreading the manuscript. The study is part of the Berlin-Brandenburg research platform BB3R (www.bb3r.de) and was funded by the German Federal Ministry of Education and Research (grant number: 031A262A) (www.bmbf.de/en/index.html).
Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
Isofluran | CP-Pharma Handelsgesellschaft mbH | 1214 | |
InfraMot - Sensore Units | TSE Systems | 302015-SENS | |
InfraMot - Control Units | TSE Systems | 302015-C/16 | |
InfraMot - Software | TSE Systems | 302015-S | |
Nestlet N | Ancare - Plexx | NES3600 | |
Camera EOS 350D | Canon |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved